JULIE CASPARY SIMEONI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner RENO, NV NPI 1932273844
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NV Acerta Pharma LLC All categories
General Payments — all program years on this page
$5,441.82
- Category: General Payments
- Program years: PY2021–2024
- Record count: 193
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,126.28 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,126.28 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $114.81 | 5 |
| E.R. Squibb & Sons, L.L.C. | $110.11 | 4 |
| Daiichi Sankyo Inc. | $82.75 | 4 |
| Genentech USA, Inc. | $81.86 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $75.84 | 3 |
| Astellas Pharma US Inc | $50.91 | 2 |
| Mirati Therapeutics, Inc. | $49.99 | 2 |
| Ipsen Biopharmaceuticals, Inc | $48.61 | 2 |
| PFIZER INC. | $46.40 | 2 |
| Incyte Corporation | $45.32 | 2 |
| ABBVIE INC. | $43.51 | 2 |
| Deciphera Pharmaceuticals Inc. | $38.64 | 1 |
| Janssen Biotech, Inc. | $34.77 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.65 | 1 |
| Kyowa Kirin, Inc. | $28.30 | 1 |
| Verity Pharmaceuticals Inc. | $28.15 | 1 |
| TAIHO ONCOLOGY, INC. | $27.54 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.56 | 1 |
| GlaxoSmithKline, LLC. | $24.99 | 1 |
| EMD Serono, Inc. | $24.90 | 1 |
| Apellis Pharmaceuticals, Inc. | $24.65 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.94 | 1 |
| Octapharma USA, Inc. | $22.82 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.78 | 1 |
| Celgene Corporation | $19.48 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.